Align Technology initiated with an Outperform at Mizuho

Mizuho initiated coverage of Align Technology (ALGN) with an Outperform rating and $295 price target Nearly every subsegment of the global dental/orthodontic market has witnessed softness over the last two years, but greater economic sensitivity of clear aligners has led to a greater delta of growth deceleration for Align than seen at other companies, notes the analyst. However, this means that as the industry potentially rebounds, Align is likely poised for the greatest lift in revenue and profit growth within the peer group in 2025-2027, the analyst argues.